Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SUMO2 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement SUMO2 dans IHC, IF et FACS. Il présente une réactivité envers Humain et Rat.
N° du produit ABIN6297478

Aperçu rapide pour SUMO2 anticorps (ABIN6297478)

Antigène

Voir toutes SUMO2 Anticorps
SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Reactivité

  • 101
  • 39
  • 36
  • 3
  • 2
  • 1
  • 1
  • 1
Humain, Rat

Hôte

  • 80
  • 25
  • 1
Souris

Clonalité

  • 81
  • 26
Monoclonal

Conjugué

  • 57
  • 9
  • 8
  • 7
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SUMO2 est non-conjugé

Application

  • 71
  • 53
  • 37
  • 21
  • 13
  • 11
  • 11
  • 9
  • 6
  • 5
  • 4
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)
  • Fonction

    Mouse anti-Human/Rat SUMO-2 Antibody [Sodium Azide Free]

    Specificité

    Nuclear

    Purification

    Recombinant human protein was used as the immunogen for the SUMO-2 antibody.

    Immunogène

    Recombinant human protein was used as the immunogen for the SUMO-2 antibody.
  • Indications d'application

    Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
    Immunofluorescence: 0.5-1 μg/mL
    Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)
    Prediluted format: incubate for 30 min at RT (2)

    Restrictions

    For Research Use only
  • Buffer

    In 1X PBS, BSA free, sodium azide free

    Agent conservateur

    Azide free

    Stock

    4 °C,-20 °C

    Stockage commentaire

    2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
  • Antigène

    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

    Autre désignation

    Small ubiquitin-related modifier 2

    Sujet

    Target Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    Gene Symbol: SUMO2///SMT3B///SMT3H2

    ID gène

    6613

    UniProt

    P61956

    Pathways

    Methionine Biosynthetic Process
Vous êtes ici:
Chat with us!